Sara Rates-Garcia

Abingdon, ENG OX143DB, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Site-selective blocking of a bioactive peptide driving neurodegeneration in the rat brain by its cyclised analogue.

Site-selective blocking of a bioactive peptide driving neurodegeneration in the rat brain by its cyclised analogue.

Journal: Molecular neurobiology

Published: March 20, 2026

Evaluating the Efficacy of Monoclonal Antibodies Against a Bioactive Peptide Involved in Alzheimer's Disease: A Methodological Approach.

Evaluating the Efficacy of Monoclonal Antibodies Against a Bioactive Peptide Involved in Alzheimer's Disease: A Methodological Approach.

Journal: Methods and protocols

Published: March 09, 2026

Therapeutic antagonism of a key toxin driving Alzheimer's disease: Comparison of a peptide variant and small molecule.

Therapeutic antagonism of a key toxin driving Alzheimer's disease: Comparison of a peptide variant and small molecule.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: October 02, 2025

Widespread Changes in the Immunoreactivity of Bioactive Peptide T14 After Manipulating the Activity of Cortical Projection Neurons.

Widespread Changes in the Immunoreactivity of Bioactive Peptide T14 After Manipulating the Activity of Cortical Projection Neurons.

Journal: International journal of molecular sciences

Published: May 09, 2025

A Novel 14mer Peptide Inhibits Autophagic Flux via Selective Activation of the mTORC1 Signalling Pathway: Implications for Alzheimer's Disease.

A Novel 14mer Peptide Inhibits Autophagic Flux via Selective Activation of the mTORC1 Signalling Pathway: Implications for Alzheimer's Disease.

Journal: International journal of molecular sciences

Published: October 27, 2024

Oxidative Stress Triggers a Pivotal Peptide Linked to Alzheimer's Disease.

Oxidative Stress Triggers a Pivotal Peptide Linked to Alzheimer's Disease.

Journal: International journal of molecular sciences

Published: October 17, 2024

A novel 14mer peptide, T14, is associated with age-dependent behaviour in female mice.

A novel 14mer peptide, T14, is associated with age-dependent behaviour in female mice.

Journal: Neurobiology of aging

Published: June 27, 2024

Evidence for a novel neuronal mechanism driving Alzheimer's disease, upstream of amyloid.

Evidence for a novel neuronal mechanism driving Alzheimer's disease, upstream of amyloid.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: January 29, 2024

A Novel Peptide Driving Neurodegeneration Appears Exclusively Linked to the α7 Nicotinic Acetylcholine Receptor.

A Novel Peptide Driving Neurodegeneration Appears Exclusively Linked to the α7 Nicotinic Acetylcholine Receptor.

Journal: Molecular neurobiology

Published: September 22, 2023

Antagonism of a key peptide 'T14' driving neurodegeneration: Evaluation of a next generation therapeutic.

Antagonism of a key peptide 'T14' driving neurodegeneration: Evaluation of a next generation therapeutic.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: July 20, 2023

A Novel Bioactive Peptide, T14, Selectively Activates mTORC1 Signalling: Therapeutic Implications for Neurodegeneration and Other Rapamycin-Sensitive Applications.

A Novel Bioactive Peptide, T14, Selectively Activates mTORC1 Signalling: Therapeutic Implications for Neurodegeneration and Other Rapamycin-Sensitive Applications.

Journal: International journal of molecular sciences

Published: May 12, 2023

Antagonising a novel toxin "T14" in Alzheimer's disease: Comparison of receptor blocker versus antibody effects in vitro.

Antagonising a novel toxin "T14" in Alzheimer's disease: Comparison of receptor blocker versus antibody effects in vitro.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: October 19, 2022

Showing 1-12 of 19

Last Updated: 09/26/2026